41 related articles for article (PubMed ID: 38720351)
1. Preliminary result of combined treatment with scanning carbon-ion radiotherapy and image-guided brachytherapy for locally advanced cervical adenocarcinoma.
Tsuchida K; Yoshida D; Shima S; Kusunoki T; Takayama Y; Koge H; Kano K; Takakusagi Y; Mizoguchi N; Kamada T; Kusano Y; Kato H; Katoh H
J Radiat Res; 2024 Jun; ():. PubMed ID: 38842119
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer.
Mobaraki A; Ohno T; Yamada S; Sakurai H; Nakano T
Cancer Sci; 2010 Aug; 101(8):1834-9. PubMed ID: 20500516
[TBL] [Abstract][Full Text] [Related]
3. Oral mucosal melanoma treated with carbon ion radiotherapy: a case report.
Musha A; Saitoh JI; Shirai K; Yokoo S; Ohno T; Nakano T
J Med Case Rep; 2016 Oct; 10(1):284. PubMed ID: 27756356
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis.
Yun JE; Kim S; Park KY; Lee W
Yonsei Med J; 2024 Jun; 65(6):332-340. PubMed ID: 38804027
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of definitive carbon-ion radiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
Isozaki T; Ishikawa H; Yamada S; Nabeya Y; Minashi K; Murakami K; Matsubara H
Esophagus; 2024 May; ():. PubMed ID: 38814482
[TBL] [Abstract][Full Text] [Related]
6. Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis.
Miyasaka Y; Kawamura H; Sato H; Kubo N; Katoh H; Ishikawa H; Matsui H; Miyazawa Y; Ito K; Suzuki K; Ohno T
Adv Radiat Oncol; 2024 Apr; 9(4):101432. PubMed ID: 38778824
[TBL] [Abstract][Full Text] [Related]
7. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
[TBL] [Abstract][Full Text] [Related]
8. Cervical Mesonephric Adenocarcinoma: A Case Report of a Rare Gynecological Tumor from Embryological Remains of the Female Genital Tract.
Reis-de-Carvalho C; Vaz-de-Macedo C; Ortiz S; Colaço A; Calhaz-Jorge C
Rev Bras Ginecol Obstet; 2021 Apr; 43(4):329-333. PubMed ID: 33784759
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.
Pors J; Segura S; Chiu DS; Almadani N; Ren H; Fix DJ; Howitt BE; Kolin D; McCluggage WG; Mirkovic J; Gilks B; Park KJ; Hoang L
Am J Surg Pathol; 2021 Apr; 45(4):498-506. PubMed ID: 33165093
[TBL] [Abstract][Full Text] [Related]
10. Relative Biological Effectiveness of Carbon Ions for Head-and-Neck Squamous Cell Carcinomas According to Human Papillomavirus Status.
Osu N; Kobayashi D; Shirai K; Musha A; Sato H; Hirota Y; Shibata A; Oike T; Ohno T
J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32722522
[TBL] [Abstract][Full Text] [Related]
11. Mesonephric adenocarcinoma of the uterine cervix with rare lung metastases: A case report and review of the literature.
Jiang LL; Tong DM; Feng ZY; Liu KR
World J Clin Cases; 2020 May; 8(9):1735-1744. PubMed ID: 32432147
[TBL] [Abstract][Full Text] [Related]
12. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
Park KJ
Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
[TBL] [Abstract][Full Text] [Related]
13. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.
Arbyn M; Weiderpass E; Bruni L; de Sanjosé S; Saraiya M; Ferlay J; Bray F
Lancet Glob Health; 2020 Feb; 8(2):e191-e203. PubMed ID: 31812369
[TBL] [Abstract][Full Text] [Related]
14. Perivascular epithelioid cell tumour and mesonephric adenocarcinoma of the uterine cervix: an unknown co-existence.
Papoutsis D; Sahu B; Kelly J; Antonakou A
Oxf Med Case Reports; 2019 Jan; 2019(1):omy115. PubMed ID: 30697432
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001).
Okonogi N; Wakatsuki M; Kato S; Karasawa K; Kiyohara H; Shiba S; Kobayashi D; Nakano T; Kamada T; Shozu M;
Cancer Med; 2018 Feb; 7(2):351-359. PubMed ID: 29341491
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
[TBL] [Abstract][Full Text] [Related]
17. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
[TBL] [Abstract][Full Text] [Related]
18. Mitotic catastrophe is a putative mechanism underlying the weak correlation between sensitivity to carbon ions and cisplatin.
Kobayashi D; Oike T; Shibata A; Niimi A; Kubota Y; Sakai M; Amornwhichet N; Yoshimoto Y; Hagiwara Y; Kimura Y; Hirota Y; Sato H; Isono M; Yoshida Y; Kohno T; Ohno T; Nakano T
Sci Rep; 2017 Jan; 7():40588. PubMed ID: 28091564
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
